Laniquidar
CAS: 197509-46-9
Ref. 3D-XHA50946
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 14 Nov 2024
Product Information
Name:
Laniquidar
Synonyms:
- 5H-Imidazo[2,1-b][3]benzazepine-3-carboxylic acid, 6,11-dihydro-11-[1-[2-[4-(2-quinolinylmethoxy)phenyl]ethyl]-4-piperidinylidene]-, methyl ester
Description:
Laniquidar is a drug that is used in cancer chemotherapy. It is a substrate for the multidrug transporter protein P-glycoprotein (P-gp) and acts as an efflux protein to minimize the uptake of other chemotherapeutic drugs. Laniquidat has been shown to be effective against hematopoietic cells and cancer cells, but not against normal cells. This drug also has drug interactions with many other drugs, such as erythromycin, ciprofloxacin, quinidine, and levofloxacin.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
584.7 g/mol
Formula:
C37H36N4O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-XHA50946 Laniquidar
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
